MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    EPIDEMIOLOGICAL OVERVIEW OF PARKINSON’S DISEASE IN BRAZIL

    S. Moura, R. Oliveira, L. Cruz, N. Cruz, A. Moura, N. Oliveira (Salvador, Brazil)

    Objective: To describe the epidemiological profile in patients hospitalized with Parkinson's Disease in Brazil during the years 2015 to 2020. Background: Parkinson's disease (PD) is…
  • MDS Virtual Congress 2021

    THE THERAPEUTIC EFFECT OF Bacopa monnieri (WATERHYSSOP) IN TREATING PARKINSON’S DISEASE

    N. Nizam, M. Ramli (Shah Alam, Malaysia)

    Objective: To determine the lethal concentration (LC50) of Bacopa monnieri aqueous extraction toward zebrafish. To analyse the behavioural study of zebrafish that has been exposed to rotenone…
  • MDS Virtual Congress 2021

    ELECTRICAL ACTIVITY OF THE MASTICATORY MUSCLES OF PARKINSONIANS INFLUENCED BY THE USE OF REMOVABLE DENTAL PROSTHESIS

    J. Oliveira, A. Sobral, T. Silva, M. Coriolano, C. Lins (Recife, Brazil)

    Objective: Analyze the influence of the types of dental prosthesis on the electromyographic activity of the masticatory muscles; masseter and temporal anterior in parkinsonians. Background:…
  • MDS Virtual Congress 2021

    FINANCIAL COST OF PARKINSON’S DISEASE IN BRAZIL IN THE LAST 10 YEARS

    R. Oliveira, S. Moura, L. Cruz, N. Cruz (Salvador, Brazil)

    Objective: Analyzing the financial cost of Parkinson's Disease in Brazil in the last 10 years Background: The Parkinson's disease is a neurodegenerative disease that when…
  • MDS Virtual Congress 2021

    COMPARISON OF FREQUENCY, CLINICAL PROFILE AND ETIOLOGIES OF PARKINSONISM IN 2008 AND 10 YEARS LATER AT THE NEUROLOGY DEPARTMENT OF BEFELATANANA UNIVERSITY TEACHING HOSPITAL, ANTANANARIVO, MADAGASCAR

    NF. Rasaholiarison, M. Ratsimandresy, JL. Rakotomanana, A. Tehindrazanarivelo (Fianarantsoa, Madagascar)

    Objective: To compare the frequency, the clinical profile of parkinsonism and its etiologies in 2008 and 10 years later in our department. Background: Number of…
  • MDS Virtual Congress 2021

    Time to diagnosis of clinically established Parkinson’s disease or atypical parkinsonism: is a 5-year follow-up period necessary?

    M. Rossi, S. Perez-Lloret, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the time frame to the diagnosis of clinically established Parkinson’s disease (PD) or atypical parkinsonism after an acute levodopa challenge (LDC) for…
  • MDS Virtual Congress 2021

    How Covid-19 would affect parkinsonism patients’ mortality

    M. Salari, M. Etemadifar, S. Tehrani Fateh, Z. Aminzade (Tehran, Islamic Republic of Iran)

    Objective: To investigate the prevalence and mortality of Covid-19 among parkinsonism patients in addition to worsening of motor symptoms of these patients. Background: Parkinsonism can…
  • MDS Virtual Congress 2021

    Parkinsonism in a patient with limbic-predominant age-related TDP-43 encephalopathy (LATE) syndrome

    C. Selvadurai, S. Schaefer (New Haven, USA)

    Objective: To illustrate a case of parkinsonism in a patient with LATE syndrome. Background: LATE syndrome is an emerging subclassification of TDP-43 proteinopathy. Symptoms include…
  • MDS Virtual Congress 2021

    Extensive volume increases sensitivity of alpha-synuclein accumulation in the gastrointestinal tract

    C. Shin, SI. Kim, SH. Park, HJ. Kim, B. Jeon (Sejong-Si, Republic of Korea)

    Objective: This study aimed to verify whether evaluation of extensive tissue volume increases sensitivity of detecting alpha-synuclein (AS) pathology in the gastrointestinal (GI) tract in…
  • MDS Virtual Congress 2021

    Early-onset vs. Late-onset Parkinson’s disease

    H. Slimène, N. Farhat, S. Sakka, O. Hdiji, M. Dammak, C. Mhiri (Sousse, Tunisia)

    Objective: To determine the clinical and therapeutic peculiarities that distinguish Early onset Parkinson’s disease (EOPD) from late onset Parkinson’s disease (LOPD). Background: Age is the…
  • « Previous Page
  • 1
  • …
  • 961
  • 962
  • 963
  • 964
  • 965
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley